Xxxxxxxx xx 31.3.2006 xx 22.9.2007 (xx xxxxxx x. 230/2007 Xx.)
Xxxxxxx č. 6 x vyhlášce x. 26/2001 Sb.
Část 1
Xxxxxx xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx xxxxxxxxx xxxxxxxxxxx, xxxxxxxxx xx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx přísad x xxxxxxxx použití
Za xxxxxxxxxxx xxxxxxx xx xxxxxxxx x soli xxxxx, uvedených v xxxxxxx č. 6. x to xxxx xxxxxxxx, sodné, vápenaté, xxxxxxxxx, xxxxxx, xxxxxxxxxxxxxx x xxxx xxxxxxxx, xxxxxxx, xxxxxx, octany x xxxxxx-, xxxxx-, xxxxxx, xxxxxxxxx-, xxxxx-, xxxxxxxx- x xxxxxxxxxxx.
Xxxxx xxxxxxxx symbolem (+) xxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxx rovněž x koncentraci jiné, xxx xx x xxxxxxx x. 6 xxxxxxx, xxx jen xxx specifické účely, xxxxx xxxx xxxxxx x xxxxxxxxxxx xxxxxx, xxxxxxxx účelu xxxxxxx xxxxxxxxxxxx xxxxxxxxxx, například xxxx dezodoranty xx xxxxx xxxx xxxxxxx xxxxx lupům xx xxxxxxx.
Xxxxxxx xxxxx xxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx mít xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxx x mohou xxx xxxxxxxxx xxxxxxxxxx xxxxxxx. Xxx například o xxxx éterických olejů x xxxxxxx xxxxxxxx. Xxxx látky xxxxxx xxxxxxxx xx přílohy x. 6.
Xxxxxxx finální xxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx formaldehyd nebo xxxxx xxxxxxxxxxx xxxxxxxxxx, xxxx být na xxxxx xxxxxxxx xxxxxxxxx "xxxxxxxx xxxxxxxxxxx", xxxxx xxxxxxxxxxx xxxxxxxxxxxx ve xxxxxxxx xxxxxxx xxxxxxxx 0,05 xxxxxxx.
___________________________________________________________________________________________
Xxx. Xxxxx Xxxxxxxxx Xxxxxxx x xxxxxxxxx Xxxxxxxx použití
číslo povolená xxxxxxxxxxx x xxxxxxxx, xxxxx musí
být xxxxxxxxx xx xxxxx
___________________________________________________________________________________________
x b c x x
___________________________________________________________________________________________
1 Xxxxxxxx benzoová•; 0,5 % v přepočtu xx kyselinu
/Benzoic xxxx/°, xxxx xxxx
x estery (+)
___________________________________________________________________________________________
2 Xxxxxxxx xxxxxxxxxx•; 2 % x přepočtu xx kyselinu
/Propionic xxxx/°x xxxx xxxx
___________________________________________________________________________________________
3 Xxxxxxxx xxxxxxxxxx•; 0,5 % x xxxxxxxx na xxxxxxxx Xxxxx xxx xxxxxxx xx xxxxxxx xxx Xxxxxxxxxx xxx xxxx
/Xxxxxxxxx xxxx /°x xxxx děti do 3 xxx x xxxxxxxx xxxxxxx. xx 3 xxx (1).
xxxx (+)
___________________________________________________________________________________________
4 Xxxxxxxx xxxxxxx (hexa- 0,6 % x přepočtu xx xxxxxxxx
-2,4-xxxxxxx xxxxxxxx)•;
/Xxxxxx acid (xxxx-2,4-
-xxxxxxx xxxx)/°x xxxx
xxxx (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx prostředky xxx Xxxxxxxx x xxxxxxxxxxxxxx
/Xxxxxxxxxxxx/°x xxxxxxx úst) aerosolů (sprejích).
paraformaldehyd• ; 0,1 % (xxxxxxxxxx xxx xxxxxxx
/Xxxxxxxxxxxxxxxx/°(+) xxx) x xxxxxxxx xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx xxxxxxxxxx
___________________________________________________________________________________________
7 Xxxxxxx.-2-xx(x-xxxxx- 0,2 % x xxxxxxxx xx xxxxx
xxxxx)•; /Xxxxxxxx-2-
-xx(x-xxxxxxxxxxxx/°)
x jeho xxxx (+)
___________________________________________________________________________________________
8 Pyrithion xxxxxxxxx• 0,5 % Xxxxxxx xxx xxx xxxxxxxxxx,
/Xxxxxxxxxx xxxx/* (+) xxxxx se xxxxxxxxx. Xxxxxxx
x xxxxxxxxxxxx xxxxx xxxxxxx.
___________________________________________________________________________________________
9 Xxxxxxxxxxx xxxxxxxxxx 0,2 % v xxxxxxxx xx xxxxx XX2
x xxxxxxxxxxxxxxxxxx
/Xxxxxxxxx xxxxxxxxx xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx xxxxx 0,1 % Xxx xxx prostředky, xxxxx
/Xxxxxx xxxxxx/° xx oplachují.
___________________________________________________________________________________________
11 Xxxxxxxxxxxx• 0,5 % Zakázáno v xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (sprejích). chlorbutanol.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % xxxx xxxxxxxx xxx xxxxx
-xxxxxxxxxxxxxxx•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % xxxx xxxxxxxx xxx xxxx
xxxx/°x xxxx xxxx a xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Acetyl-6-methyl-2,3- 0,6 % x přepočtu xx xxxxxxxx Xxxxxxxx x xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (xxxxxxxx).
-xxxx•; /Xxxxxx-6-xxxxxx-
-xxxxx-2,4(3X)-xxxxx
(Xxxxxxxxxxxxx xxxx)/°
x jeho soli
___________________________________________________________________________________________
14 Xxxxxxxx xxxxxxxx•; 0,5 v xxxxxxxx xx xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx sůl/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x xxxx soli xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Xxxxxxxxxx/* 0,007 % (xxxx Xx) ve xxxxx x Pouze xxx prostředky k xxxxxx Xxxxxxxx xxxxxxxxxx.
xxxxxxxxx xxxxxxxxxxxx xxxxx a odličování xxx.
xxxxxxxxxx xxxxx xxxxxxxxx
xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % Hg
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx soli• 0,007 % (jako Hg) xx xxxxx x Xxxxx pro xxxxxxxxxx x xxxxxx Xxxxxxxx
(xxxxxx borátu) xxxxxxxxx xxxxxxxxxxxx xxxxx x xxxxxxxxxx okolí očí. fenylrtuťnaté
/Phenylmercuric xxxxx xxxxxxxxxx xxxxx xxxxxxxxx xxxxxxxxxx.
(xxxxxxxxx borate)/° zůstává xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Xx
___________________________________________________________________________________________
18 Kyselina xxxx-10-xxxxx•; 0,2 % x xxxxxxxx na xxxxxxxx
/Xxxxx-10-xxxxx xxxx/°
x xxxx soli(+)
___________________________________________________________________________________________
19 Xxxxxxxxx 0,1 %
/Hexetidine/* (+)
___________________________________________________________________________________________
20 5-brom-5-nitro-1,3-dioxan 0,1 % Xxx xx xxxxxxxxxx, xxxxx xx
(Xxxxxxxx)• /5-Bromo-5- oplachují.
-nitro-1,3-dioxane/° Zamezit xxxxxx nitrosaminů.
___________________________________________________________________________________________
21 Xxxxxxxx /Bronopol/* (+) 0,1 % Zamezit xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
xxxxxxx• /2,4-Xxxxxxxx-
xxxxxx xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Kriteria xxxxxxx: 3,3´,4,4´-
/Xxxxxxxxxxxx/* (+) xxxxxxxxxxxxxxxxxxx méně xxx 1
xxx 3,3´,4,4´-xxxxxxxxxxxxxxx-
xxxxxx xxxx xxx 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Xxxxxxx v xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx xx kontaktu
se xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Xxxxxxxxx/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-chlor-3,5-dimethylfenol)•
/4-Chloro-3,5-xylenol/°(+)
___________________________________________________________________________________________
27 3,3´-Xxx[1-(xxxxxxx- 0,6 %
xxxxxx)-2,5-xxxxxxxxxx-
xxxxxxx-4-xx]-1,1´-
xxxxxxxxxxxxxxxxxx
(xxxxxxxxxxxxxxxxxxxxxx)•
/3,3´--Xxx(1-xxxxxxx-
xxxxxx-2,5-xxxxxxxxxx-
xxxxxxx-4-xx)-1,1´-xxxxxx-
xxx-xxxxx ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Poly-1-hexamethylen 0,3 %
xxxxxxxx-xxxxxxxxxxxx•
/Xxxx-(1-xxxxxxxxxx-
xxxxxxxxxxx xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Xxxxxxxxxxx-1-xx• 1 %
/2-Phenoxyethanol/°(+)
___________________________________________________________________________________________
30 Xxxxxxxxxxxxxxxxxxxx 0,15 %
(xxxxxxxxxx, xxxxxxxxx)•
/Xxxxxxxxxxxxxxxxxxxxx
(xxxxxxxxxxx*)/°(+)
___________________________________________________________________________________________
31 Xxxxxxxxxx-3-xxxxxx- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Xxxxxxxxxxx)-1- 0,5 %
(imidazol-1-yl)-3,3´-
dimethylbutan-2-on•
/1-(4-Chlorophenoxy)-
-1-(imidazol-1-yl)3,3-
-dimethylbutan-2one/°
(+)
___________________________________________________________________________________________
33 1,3-Xxx(xxxxxxxxxxxxx)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Xxx
(xxxxxxx-xxxxxx)-5,5-
-xxxxxxxx-xxxxxxxxxxxxx-
-2,4-xxxxx/°(+)
___________________________________________________________________________________________
34 Xxxxxxxxxxxxx• 1 %
/Xxxxxx alcohol/°
___________________________________________________________________________________________
35 1-Xxxxxxx-4-xxxxxx-6- 1 % Xxx xxxxxxxxxx, xxxxx xx xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Pro xxxxxxx xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx s xxxxxxxxxx-
xxxxxxx• (xxxxxxxxx) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx pro xxxxxxxxxx, xxxxx
xxxxxxxxxxx• xx xxxxxxxxx.
/1,2-Xxxxxxx-2,4-
-xxxxxxxxxxxxx°
XXXXXXXXXXXXX
XXXXXXXXXXXXXX•
___________________________________________________________________________________________
37 6,6´-Xxxxxx-4,4-´xxxxxxx- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-xxxxxxxxx-3-xxxxxxxxxxx)•
/4-Xxxxxxxxx-x-xxxxxx/°
___________________________________________________________________________________________
39 Směs 5-xxxxx-2-xxxxxx- 0,0015 % (Xxxx v xxxxxx 3 :1
-xxxxxxxxxx-3(2X)-xxx• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx a 2-methylisothiazol-3(2H)-on
sothiazol-3(2H)-one/°a
2-methylisothiazol-3(2H)-
-onu• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x xxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxxx/°x xxxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxx/°
___________________________________________________________________________________________
40 2-Xxxxxx-4-xxxxxxxxxx• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Obsahuje
/2-Chloracetamide/° chloracetamid.
___________________________________________________________________________________________
42 Chlorhexidin• 0,3 % v xxxxxxxx xx xxxxxxxxxxxx
/Xxxxxxxxxxxxx/* x xxxx
xxxxxxxxxx, /xxxxxxxxxxx/°,
xxxxxxxx /xxxxxxxxx/ x
xxxxxxxxxxxxxx
/xxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
43 1-Fenoxypropan-2-ol• 1,0 % Xxx xxx xxxxxxxxxx, xxxxx xx
/1-Xxxxxxxxxxxxx-2-xx/° xxxxxxxxx.
___________________________________________________________________________________________
44 Xxxxx (X12 - X22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -xxxxxxx•
/Xxxxx (X12 - X22) trimethyl
ammonium-bromide
a xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % xX konečného xxxxxxxx xxxxx
-xxxxxxxxxx• /4,4-Di- být xxxxx než 6.
methyl-1,3-oxazolidine/
___________________________________________________________________________________________
46 1-[1,3-Xxx(xxxxxxx- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Xxxxx-1,6-xxxxxx- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x jeho xxxx xxxxxx
xxxxxxxxxxx (2-xxxxxxx-
-xxxxx-1-xxxxxxxxx)•
/xxxxxxxxxxx/°x 4-xxxxx-
xxxxxxxxxx• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Xxxxxxxx x xxxxxxxxxxxxxx Xxxxxxxx
(xxxxxxxxxx)• xxxxxxxx (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (xxx obsahu
(Pentane-1,5-dial)/° xxxxxxxxxxxxxx x
xxxxxxxx produktu
vyšším xxx 0,05 %)
___________________________________________________________________________________________
49 5-Xxxxx-3,7-xxxxx-1- 0,3 % Xxxxxxx x xxxxxxxxxxxx xxxxx
-xxxxxxxxxx[3.3.0]xxxxx• xxxxxxx a x xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx do xxxxxxxx
-xxxxxxxxxx[3.3.0] xx xxxxxxxx.
xxxxxx/°
___________________________________________________________________________________________
50 3-(4-Xxxxxxxxxxx)-xxxxxx- 0,3 %
-1,2xxxx• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx sodný, X-(xxxxxxx-
xxxxxx)-xxxxxxxx xxxxx,•
/Xxxxxx hydroxymethyla-
minoacetate, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx xxxxxxxx zakot- 0,004 % x přepočtu xx AgCl 20 % (xxxxx.)XxXx xx XxX2
xxxx xx oxidu xxxxxxxxxxx Zakázán v xxxxxxxxxxxx pro xxxx xx
/Xxxxxx xxxxxxxx xxxxxxxxx 3 xxx, x xxxxxxxxxxxx ústní xxxxxxx
xx Xxxxxxxx xxxxxxx/° x x xxxxxxxxxxxx aplikovaných xx
xxxxx xxx x xx xxx.
___________________________________________________________________________________________
53 Xxxxxx{2-[2-(xxxxxxxxxxxx- 0,1 % x) xxxxxxxxxx, xxxxx xx xxxxxxxxx;
xxxx)xxxxxx]xxxxx}xx- x) xxxxxxxxx, xxxxx zůstávají na xxxx, xxxxx xxxxxxxxxx
xxxxxxxxxxxxx-xxxxxxx xxx xxxx o xxxxxx xxxxx
Xxxxxxxxxxxx-xxxxxxx•
XXXXXXXXXXXX CHLORIDE°
___________________________________________________________________________________________
54 Alkyl(C8 - X18) (benzyl) 0,1 % x xxxxxxxx xx Xxxxxxx xxxxx x xxxxx.
xxxxxxxxxxxxxxx-xxxxxxx, xxxxxxxxxxxx-xxxxxxx
-xxxxxx x xxx s cukernou
kyselinou (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx x xxx s
cukernou kyselinou)•
/Benzalkonium xxxxxxxx,
xxxxxxx xxx
xxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
55 Benzylhemiformal 0,15 % Xxx xxx xxxxxxx, xxxxx xx
(xxxxxxxxxxxxxxxxx)• odstraňují xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Nesmí xx xxxxxxxx v Xxxxxxxx jod.
-butylkarbamát• xxxxxxxxxxxx xxxxx xxxxxxx x v
/3-Iodo-2-propynyl-butyl- prostředcích k xxxx o xxx.
xxxxxxxxx/° 2. Xxxxx xxxxxxxxxxx x
xxxxxxxxxxxx, xxxxx xxxx určeny
k xxxx, xxx xxxxxxxxx xx
xxxxxxx, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Xxxxxxxx jod.
___________________________________________________________________________________________
57 2-methylisothiazol- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Xxxxx xxxxx xxx xxxxxxx, xxxxx xx xxxxx xxx xxxxxxx xxx xxxx xx 3 let x xxxxx xxxxxxxxx x xxxxxxxxxxxx xxxxxxxx x kůží.
(*) X xxxx příloze je xxxxx xxxxxxxx označen xxxxx xxxxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx xxxxx xxx xxxxxxxxxxxxx xxxxxxx "Xxxxxxxx xxxxx-xxx 1975, Xxxxxxxxxxxxx Xxx-xxxxxxxxxxx Xxxxx (INN) xxx xxxxxxxxxxxxxx xxxxxxxx Xxxxx 1,33 xx xxxxxxxx XXX", XXX, Xxxxxx, Xxxxxx 1975.
(•) X xxxx příloze je xxxxx xxxxxxxx xxxxxxx xxxxx vytvořený xxxxx "Xxxxxxxx názvoslovím organických xxxxxxxxx podle XXXXX (Xxxxxxxxxx 1993)", Academia, Xxxxx 2000.
(°) X xxxx příloze xx xxxxx xxxxxxxx xxxxxxx xxxxx v xxxxxxxxx xxxxxx, převzatý x xxxxxxxxx "The Xxxxxxxxx Xxxxxxxxx 76/768/XXX", Colipa, Xxxxxxxx, Xxxxx 2000.
Část 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx xxxxxxxxxx x xxxxxxxxxxxx prostředcích, nejvyšší xxxxxxxxx xxxxxxxxxxx, požadavky xx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx přísad a xxxxxxxx xxxxxxx
_______________________________________________________________________________________
Xxx. číslo Látka Maximální Xxxxxxx x Xxxxxxxx xxxxxxx x xxxxxxxx,
xxxxxxxx xxxxxxxxx xxxxx xxxx xxx vytištěna xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x x x x x
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Xxxxxxxx: X xxxxxxxx xxxx xxxx xxxxxxx xxxxxxxxxx xxxxxx xxxxx.